Bandita Parhy
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
Hepatitis C virus research, Hepatitis B Virus Studies, Liver Disease Diagnosis and Treatment, HIV/AIDS drug development and treatment, Viral Infections and Immunology Research
Most-Cited Works
- → Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes(2018)307 cited
- → Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification(2019)116 cited
- → Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11(2018)111 cited
- → Ledipasvir‐Sofosbuvir for 12 Weeks in Children 3 to <6 Years Old With Chronic Hepatitis C(2019)93 cited
- → No Resistance to Tenofovir Alafenamide Detected through 96 Weeks of Treatment in Patients with Chronic Hepatitis B Infection(2018)60 cited
- → Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection(2019)60 cited
- → Resistance characterization of ledipasvir and velpatasvir in hepatitis C virus genotype 4(2017)27 cited
- → Identification of genes induced in proteoid roots of white lupin under nitrogen and phosphorus deprivation, with functional characterization of a formamidase(2010)26 cited
- → Development of Electrochemiluminescent Serology Assays to Measure the Humoral Response to Antigens of Respiratory Syncytial Virus(2016)18 cited
- → Sofosbuvir–velpatasvir in children 3–17 years old with hepatitis C virus infection(2024)17 cited